- Home
- ARMP vs NAUT Comparison
ARMP vs NAUT Comparison
Compare ARMP & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- NAUT
- Stock Information
- Founded
- ARMP N/A
- NAUT 2016
- Country
- ARMP United States
- NAUT United States
- Employees
- ARMP N/A
- NAUT N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- ARMP Health Care
- NAUT Industrials
- Exchange
- ARMP Nasdaq
- NAUT Nasdaq
- Market Cap
- ARMP 92.4M
- NAUT 95.6M
- IPO Year
- ARMP N/A
- NAUT N/A
- Fundamental
- Price
- ARMP $2.61
- NAUT $0.70
- Analyst Decision
- ARMP Strong Buy
- NAUT Strong Sell
- Analyst Count
- ARMP 1
- NAUT 1
- Target Price
- ARMP $9.00
- NAUT $1.75
- AVG Volume (30 Days)
- ARMP 9.3K
- NAUT 202.0K
- Earning Date
- ARMP 08-12-2025
- NAUT 07-31-2025
- Dividend Yield
- ARMP N/A
- NAUT N/A
- EPS Growth
- ARMP N/A
- NAUT N/A
- EPS
- ARMP N/A
- NAUT N/A
- Revenue
- ARMP $6,868,000.00
- NAUT N/A
- Revenue This Year
- ARMP $8.43
- NAUT N/A
- Revenue Next Year
- ARMP N/A
- NAUT N/A
- P/E Ratio
- ARMP N/A
- NAUT N/A
- Revenue Growth
- ARMP 84.67
- NAUT N/A
- 52 Week Low
- ARMP $0.90
- NAUT $0.66
- 52 Week High
- ARMP $2.96
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- ARMP 58.67
- NAUT 44.44
- Support Level
- ARMP $2.43
- NAUT $0.67
- Resistance Level
- ARMP $2.72
- NAUT $0.76
- Average True Range (ATR)
- ARMP 0.18
- NAUT 0.04
- MACD
- ARMP -0.01
- NAUT -0.00
- Stochastic Oscillator
- ARMP 70.08
- NAUT 29.29
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.